ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,279, issued on Sept. 23, was assigned to Drexel University (Philadelphia).
"Cyclic peptide antiviral agents and methods using same" was invented by Irwin M. Chaiken (Gladwyne, Pa.) and Adel Ahmed Rashad Ahmed (Philadelphia).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes novel cyclic peptides, and methods of using the same. The present invention further includes novel cyclic peptides conjugated with a gold nanoparticle, and methods of using the same."
The patent was filed on Feb. 28, 2024, under Application No. 18/589,590.
*For further information, including images, charts and tables, please visit: http://patft.uspto....